Abstract
Prohormone convertase (PC) 1/3 and PC2 are neuroendocrine-specific enzymes that convert prohormones to active hormones. To learn more about the role of these PCs in normal and neoplastic islet cells, we analyzed a series of pancreatic endocrine tumors to determine the role of PC1/3 and PC2 in islet cell hormone processing. In situ hybridization with insulin and glucagon probes and immunostaining with antibodies to PC1/3 and PC2 were done with 6 normal pancreases, 33 insulinomas, and 7 glucagonomas. The intensity of the reactions was graded from 0 to 3+. Normal islets stained strongly for both proinsulin and proglucagon mRNAs. Insulinomas and glucagonomas had readily detected hormone mRNAs for proin sulin and proglucagon, respectively. Normal pancreatic insulin cells stained weakly for PC1/3 (1+) and PC2 (1−2+), and glucagon cells stained weakly for PC1/3 (1−2+) and strongly for PC2 (2−3+). Both insulinomas and glucagonomas stained strongly for PC2 (2−3+) with less intense staining for PC1 (1−2+). These results indicate that PC2 is more highly expressed in insulin- and glucagon-producing pancreatic islet cell tumors and that there is increased expression of PC2 in insulinomas compared to normal insulin-producing cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Marcinkiewicz M, Day R, Seidah NG, Chretien M. Ontogeny of the prohormone convertase PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropins. Proc Natl Acad Sci USA 90:4922–4926, 1993.
Steiner DF, Smeekens SP, Ohagi S, Chan SJ. The new enzymology of precursor processing endoproteases. J Biol Chem 267:23,435–23,438, 1992.
Lindberg I. The new eukaryotic precursor processing proteinases. Mol Endocrinol 5:1361–1365, 1991.
Seidah NG, Chretien M. Pro-protein convertases of subtilisin/kexin family. Methods Enzymol 244:175–188, 1994.
Bloomquist BT, Eipper BA, Mains RE. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 5:2014–2024, 1991.
Seidah NG, Day R, Hamelin J, Caspar A, Collard MW, Chretien M. Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase. Mol Endocrinol 6:1559–1570, 1992.
Lusson J, Vieau D, Hamelin J, Day R, Chretien M, Seidah NG. cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and non-endocrine cells. Proc Natl Acad Sci USA 96:6691–6695, 1993.
Scopsi L, Gullo M, Rilke F, Mortin S, Steiner DF. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J Clin Endocrinol Metab 80:294–301, 1995.
Lloyd RV, Jin L, Qian X, Scheithauer BW, Young WF Jr, David DH. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. Am J Pathol 146:1188–1198, 1995.
Lloyd RV. Overview of neuroendocrine cells and tumors. Endocr Pathol 7:323–328, 1996.
Kajiwara H, Tanaka S, Itoh Y, Tsutsuri Y, Osamura RV. Expression of endoprotease furin, prohormone convertase (PC) 1/3 and PC2 in pulmonary neuroendocrine lesions: correlation of functional differentiation of neuroendocrine cells with post-translational processing of prohormones. Endocr Pathol 10:85–94, 1999.
Itoh Y, Tanaka S, Takekoshi S, Itoh J, Osamura RY. Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: subcellular immunohistochemical analysis. Pathol Int 46:726–737, 1996.
Takumi I, Steiner DF, Sanno N, Teramoto A, Osamura RY. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Modern Pathol 11:232–238, 1998.
Marcinkiewicz M, Ramla D, Seidah NG, Chritien M. Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets. Endocrinology 135:1651–1660, 1994.
Tanaka S, Kurabuchi S, Mochida H, Kato T, Takahashi S, Watanabe T, Nakayama K. Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets. Arch Histol Cytol 59:261–271, 1996.
Lloyd RV, Schroeder G, Bauman MD, Krook JE, Jin L, Goldberg RM, Forr GH Jr. Prevalence and prognostic significance of neuroendocrine differentiation in colorectal carcinomas. Endocr Pathol 9:35–42, 1998.
O’Rahilly S, Gray H, Humphrey P, Krook A, Pulonsky KS, White A, Gibson S, Taylor K, Corr C. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med 333:1386–1390, 1995.
Furuta M, Yano H, Zhou A, Rouille Y, Holst JJ, Carroll R, Rarazzola M, Orci L, Furuta H, Steiner DF. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94:6646–6651, 1997.
Westphal CH, Muller L, Zhou A, Zhi X, Bonner-Weir S, Schanbelan M, Steiner DF, Lindberg I, Leder P. The neuroendocrine protein 7BZ is required for peptide hormone processing in vivo and provides a novel mechanisms for pituitary Cushing’s disease. Cell 96:689–700, 1999.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodacker, M., Jin, L., Zhang, S. et al. Insulin and glucagon mRNA expression and prohormone convertase immunoreactivity in normal and neoplastic pancreatic endocrine tissue. Endocr Pathol 11, 179–183 (2000). https://doi.org/10.1385/EP:11:2:179
Issue Date:
DOI: https://doi.org/10.1385/EP:11:2:179